Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
who ARE you people?
Why do you have such a high risk tolerance? Gambling is one thing, but you people act like you put a pretty big wager on this zombie.
For example, dcspka paid about a $15 per share when he started "touting" this stock and the merger/takeover. That is adjusted for the split, of course. If dcspka sold 320 of those shares today, he could take a $4480 tax loss.
One of our resident "Longs" might argue that $4480 is peanuts and nobody would bother.... but those same "Longs" talk about 10 million shares in a day being "huge volume." $4480 worth of RXPC traded would be a 44 million share day, which would shock us all.
ahhhhh.... runncoach, where is kenman when you need him? He was the A-list "Long." The last time I saw kenman post, he was loading up on Microsoft because he thought Bing was going to change the world. I told him "I hate Bing." Today I still hate Bing. I stopped using IE and now use Firefox exclusively, all because of Bing. Whenever I accidentally use IE and Bing tries to send me somewhere I had no intention of going.... I think of kenman.
what is YOUR current position worth, dcspka?
I know when you bought your "position as a serious purchase."
Here is another question for you. If CIT is worth developing, why did Radient/NuVax abandon it in December 2010 and license Chang's newer technology from the University of Florida in January 2011?
UofFl has Chang. They have no use for Radient/NuVax.
You apparently don't realize that Radient/NuVax was paying UofFl, not the other way around.
Radient/NuVax has no resources that the University of Florida wants or can use.
Again, I suggest you read the SEC Filings. Here is a timeline of what happened:
early December 2010: NuVax hires Bhatia and Chang.
late December 2010: NuVax abandons CIT.
January 2011: NuVax pays the University of Florida to license Chang's newer technology. They pay them with NuVax shares (and maybe some cash).
July 2011: Radient goes broke. They cannot pay Bhatia or Chang.
Chang quits, Bhatia quits. The University of Florida terminates the agreements. NuVax has nothing except CIT, which they have already declared is worthless.
So the University of Florida is left holding some NuVax shares. That and a dollar won't buy a cup of coffee.
The Univ of Florida knows better than anyone what NuVax is worth.
If they could sell them for $1 and take the loss, they would. But they have no way of dumping those "shares." Nobody can buy them. Nobody WOULD buy them.
Read the 10-K. CIT is worthless and NuVax is nothing more than a name on paper.
Radient's last 10-K says CIT is worthless.
blackpantherz, here is the link to the 10K. Go to page 11. Do some DD. Learn to trust SEC filings and not message board chatter and rumors.
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=8697129-1048-659364&type=sect&TabIndex=2&companyid=4985&ppu=%252fdefault.aspx%253fcik%253d838879
Radient says that CIT is worthless and took a final impairment of $1 million. That's about what they paid for CIT back in 2000.
"Due to the following conditions at December 31, 2010, we decided to impair the remaining balance of our CIT asset:
· Lack of any potential future revenue;
· Lack of future cash flows;
· High cost of future clinical studies; and
· Limited time remaining on the patent."
"In January 2011, NuVax signed four exclusive license agreements with the University of Florida Research Foundation, Inc. (“UFRF”), for the development and marketing of a cancer therapeutic product developed by the UFRF. In July 2011, the UFRF terminated the agreements due to lack of funding. "
Let me summarize. Radient realized that CIT was worthless in Dec 2010. They tried to work with Bhatia and Chang on Chang's newer technology, "a cancer therapeutic product developed by the UFRF," NOT CIT, but Radient ran out of money and Bhatia and Chang and the Univ of Florida all quit.
I think Gartner just wanted to mimic Mac's business model of "forecast profits, burn cash, pay yourself a huge salary, and apologize when the money's gone." He needed a couple $$$ million to work that game and he never got it.
Selling DR-70 on the internet is an absurd plan. But in the business model above, you never need to sell a single test kit. You simply need to convince an investor that it would work. Unfortunately, the investor would eventually get around to reading Radient's 10-Q's and 10-K's, and no intelligent investor would give Gartner money after THAT.
I think former CEO Dreher, current CEO MacLellan, Reyno, Boswell, Beart, and Aiura all knew that DR-70 would never be profitable. That did not stop them from collecting BIG salaries and awarding themselves bonuses. It lasted two years longer than I thought possible. They can thank Garza for that. The lenders must not be feeling as grateful.
if you mean "members of the class," then...
Feuerstein? absolutely not. He didn't but RPC shares.
Garza? probably not. That would mean Garza bought shares after his second round of "bullish coverage" in January 2011. That's not how Garza makes money. He would NOT "buy his own news."
And besides, there will be no award money. Rosen might win -- in fact he will probably win if it goes in front of a jury -- but Radient has zero money to pay an award so there is NOT going to be any money for the members of the class.
If you mean "are those two getting sued?" then the answer is no. Garza in particular has a huge disclaimer stating that he cannot be sued or held responsible for anything he says. That gives him free rein to say ANYTHING.
we will know in less than four weeks.
My guess proved wrong -- I thought Mac would file right after Labor Day. I thought he'd wait that long for Gartner to get funding and then pull the plug.
I think Gartner's Fundable project was a last-ditch effort to come up with $20,000 to buy a license agreement from Mac before the BK filing. The Fundable project was an embarrassing failure, IMO. I don't think we will hear from Gartner again, although he didn't take down his GCDx website yet.
Reminds me of the Guar Diagno website with the fake testimonials and the pictures of the white van.
Interesting. Christiansen botched the PortaCom merger in 1996 with MacLellan.
http://www.arkansasbusiness.com/article/76137/portacom-asian-american-merger-tripped-by-taxes
Christiansen, the CFO, apparently didn't understand the tax implications. Treading was halted when the stock tanked.
That was September 1996. Within weeks of this debacle, Christiansen quit or was fired from PortaCom.
on MacLellan's Linked-In page, it says " Mr. MacLellan left PortaCom in March 1998 to pursue multiple China based telecommunications opportunities. " That's a polite way to say it -- PortaCom filed for bankruptcy of PortaCom in March 1998.
Here's a fun drinking game -- go to Mac's LinkedIn page:
http://www.linkedin.com/in/douglasmaclellan
Now read his CV and take a shot of whiskey every time you see the name of a company that Mac drove into BK or turned into a zombie.
but don't plan on driving for a while because you're going to be too drunk to drive.
that does not answer my question - I asked you to finish your sentence -- why did Radient do the reverse split?
We've all read Mayo's statement. Why do you think they felt the need to release that statement?
"In today's litigious society almost all cases are allowed to proceed. "
That statement is nonsense.
A judge reviewed the lawsuit, dismissed the complaint against Ariura, and "found that there were genuine disputes of material fact as to whether Radient and MacLellan committed securities fraud and denied their motions for summary judgment."
The judge did not let the case "proceed" simply because that's what always happens in "today's litigious society."
Radient also claims to own 98% of Jade.
I think you should call the U of Florida and offer to give them $610 for their NuVax shares. I bet they accept. That's $610 more than they are going to get anywhere else.
BTW You didn't finish your sentence -- Radient did a reverse split to keep certain entities from WHAT?
I thought they did the multiple reverse splits to pay off lenders. And it didn't do much good because the PPS went into a freefall. Five billion shares doesn't come close to paying off $20 million in debt when the PPS plummets to .0001
And what "stretegic rollout plan" are you talking about? Radient doesn't operate, they don't manufacture, they're not paying off their debt -- Radient doesn't do anything except shop around license agreements. If they get $100,000 per year for each continent the way they just got $100,000 annually for Asia sales, they will be raking in $700,000 per year max, which doesn't come CLOSE to keeping up with the interest on the defaulted loans.
This is really quite simple math. Radient is a zombie.
Your opinion is based on what, exactly?
Why will RXPC run big in November?
What catalyst will cause that to happen?
Thanks in advance.
The last time Radient had to pay their lawyers they printed shares. They don't have enough shares left in the A/S to pay for trial lawyers. How will the Corporation appear in court in November without lawyers?
Radient has no money to repair this ship.
They've been broke since December 2011. Read the SEC filings.
Any outside entity could simply license DR-70 and ALL ITS INTELLECTUAL PROPERTY if they wanted to try and sell it. Read the SEC filings. Radient tried to license the test to GCDx in 2012 but GCDx could not come up with funding. Radient is trying to license the test to UNI in 2013 but we don't know whether UNI bailed or not.
The question is: why would an outside entity try to sell DR-70? AMDL/Radient tried from 1996 through 2011 and failed. That failure was not "we missed our revenue projections by a little bit," it was "we missed our revenue projections by 95%." Not once, but EVERY YEAR THEY GAVE GUIDANCE.
Yes, 95%. As in, the CEO MacLellan gave guidance of $2 million but produced only $100,000. what kind of company allows their CEO to miss guidance by that much?
DR-70 is a failure of epic proportions. And every year the biotech industry leaves it farther behind in the dust.
Who will pay the lender debt to right this ship?
This ship is not merely listing in the harbor. It is run aground and rotting. Better to build a new ship than try to repair this one.
SEC will never halt RXPC.
They let zombie pinksheets like this stagger around forever. The SEC doesn't care what make-believes, or you, or the CEO's of zombie stocks do in the pinksheets.
I think the CEO will file for BK because the corporation has no money for trial lawyers in November. Maybe I'm wrong, maybe not. Maybe the lenders finally force BK just to get closure.
I use quotation marks around the word "long," you will notice. There is no such thing as a long in the pinksheets -- only traders who are anticipating a play or who got caught holding the bag.
There is no takeover. that is just a fantastixc rumor created by a "long" in 2011. This stock has fallen a LONG way since then, but the rumor persists simply because there is nothing else on which "longs" can hang their carnical hats.
There's no evidence that Global Cancer diagnostics will ever sell the test. In the unlikely event that they do start selling it, the SEC will shut them down in a matter of weeks, just as they shut down the company selling the online DNA test.
Why did GCDx drop out of the Fundable contest and drop off the Fundable website?
Small-Howard pursues the patent because it's cheap to do so, and there's no reason not to, regardless of whether the company goes bankrupt or not.
Radient/AMDL has had patents on this test for 20 years.
Patents don't always mean profits or revenues or success.
Another patent isn't going to make any difference.
So yes, your references to patents constitute hype.
Nothing is coming RXPC's way except a jury.
why do you care about underdawg?
the blog has been taken over by wolfman and littered with his unsubstantiated buyout rumor.
He can't spell "equivalent." the old underdawg could at least spell.
"Radient is controlling the Global Cancer Diagnostics market behind the scenes?" Why read such nonsense?
looks like GCDx dropped out of the Fundable contest.
They were getting left in the dust by the Faith shirts, the shopping app, and the booze cookies.
They are still soliciting money on Fundable, so the longs can still get lifetime DR-70 testing for $1000.
The longs have been claiming the contest was just a publicity stunt for GCDx because GCDx is part of a multi-million-dollar Radient merger and is therefore fully funded. Funny.... you'd think that winning the contest would have been good publicity. All the takeover groups [sic] had to do was pledge $10,000 to win the contest and get some free positive press.....
But in retrospect, this wasn't very good publicity, IMO. On the contrary -- I found it to be embarrassing for GCDx.
yes runncoach, I know you are one of the few people here who truly understand this company.
My take on the positive posts in February:
1. SRL hype caused high volume starting on Feb. 1st, resulting in a lot of RXPC shares in new hands the first week of February.
2. That volume allowed the lenders to convert a large portion of the remaining A/S.
3. The new group of RXPC shareholders bought solely on the volume without doing DD - a strategy that often works in the pinksheets. In this case, the volume dried up quickly, and they started doing a little DD. They didn't like what they found.
4. Result: there were lots of posts on this message board in february that were very, very positive... from shareholders who wanted to sell.
I am looking for a bankruptcy 8-K before the jury trial in November. If I am right about that, I don't expect it on November 11th... I expect it in September. I think MacLellan is waiting for Gartner to get funding so they can sign a license agreement with a bankruptcy clause similar to the UNI agreement, but, I don't think MacLellan will wait much longer.
This is still the best story on wall street! But I think we finally get closure in the next 30 days.
SRL pumps hit the wires on February 1st. Example:
http://health.india.com/news/onko-sure-a-blood-test-to-screen-13-types-of-cancers/
Regarding the current patent application, Here is the Transaction History -- unfortunately the new application has not been Forwarded to the Examiner yet. Nothing has happened since 02/28.
Date Transaction Description
02-28-2013 Electronic Information Disclosure Statement
02-28-2013 Information Disclosure Statement (IDS) Filed
02-27-2013 Mail Interview Summary - Applicant Initiated - Telephonic
02-20-2013 Interview Summary- Applicant Initiated
02-20-2013 Interview Summary - Applicant Initiated - Telephonic
02-20-2013 Date Forwarded to Examiner
02-15-2013 Request for Continued Examination (RCE)
02-20-2013 Disposal for a RCE / CPA / R129
02-15-2013 Request for Extension of Time - Granted
02-15-2013 Workflow - Request for RCE - Begin
08-21-2012 Electronic Review
08-18-2012 Email Notification
08-17-2012 Mail Final Rejection (PTOL - 326)
08-13-2012 Final Rejection
06-16-2012 Date Forwarded to Examiner
04-27-2012 Response after Non-Final Action
04-24-2012 Email Notification
04-24-2012 Mail Notice of Informal or Non-Responsive Amendment
02-15-2012 Date Forwarded to Examiner
02-13-2012 Informal or Non-Responsive Amendment after Examiner Action
02-13-2012 Response after Non-Final Action
02-07-2012 Email Notification
02-07-2012 Mail Notice of Informal or Non-Responsive Amendment
01-26-2012 Affidavit(s) (Rule 131 or 132) or Exhibit(s) Received
01-31-2012 Date Forwarded to Examiner
01-26-2012 Informal or Non-Responsive Amendment after Examiner Action
01-26-2012 Response after Non-Final Action
01-26-2012 Request for Extension of Time - Granted
09-29-2011 Electronic Review
09-27-2011 Email Notification
09-27-2011 Mail Non-Final Rejection
09-12-2011 Non-Final Rejection
10-26-2009 Information Disclosure Statement considered
01-25-2010 Information Disclosure Statement considered
07-18-2011 Date Forwarded to Examiner
07-07-2011 Response to Election / Restriction Filed
06-10-2011 Electronic Review
06-10-2011 Email Notification
06-10-2011 Mail Restriction Requirement
06-06-2011 Restriction/Election Requirement
10-01-2010 Email Notification
09-30-2010 PG-Pub Issue Notification
01-25-2010 Electronic Information Disclosure Statement
10-26-2009 Electronic Information Disclosure Statement
01-25-2010 Information Disclosure Statement (IDS) Filed
01-25-2010 Case Docketed to Examiner in GAU
10-26-2009 Information Disclosure Statement (IDS) Filed
07-01-2009 Application Dispatched from OIPE
06-15-2009 Change in Power of Attorney (May Include Associate POA)
06-12-2009 Sent to Classification Contractor
06-15-2009 Filing Receipt - Updated
06-05-2009 Additional Application Filing Fees
06-05-2009 A statement by one or more inventors satisfying the requirement under 35 USC 115, Oath of the Applic
06-05-2009 Applicant has submitted new drawings to correct Corrected Papers problems
05-04-2009 Filing Receipt
05-04-2009 Notice Mailed--Application Incomplete--Filing Date Assigned
04-20-2009 Cleared by L&R (LARS)
04-01-2009 Referred to Level 2 (LARS) by OIPE CSR
03-30-2009 IFW Scan & PACR Auto Security Review
03-30-2009 Initial Exam Team nn
If you had a volume alert set at 80 million, which apparently you did, then yes, a manipulator triggered your volume alert.
The 500 million volume starting on February 1st was from the SRL hype.
Where's the volume now? Without more hype, you're not going to see any.
Whoever is holding RXPC shares now has taken over Radient? Do they know that? Have the lenders contacted them asking for plans to repay the defaulted loans?
underdawg wrote that in June?
That sure looks like wolfman wrote it in the wee hours.
and I notice that underdawgs posts keep disappearing on seeking alpha. Why is that?
Volume in January was under 80 million shares a day in the last week, under 10 million shares before that.
In the pinksheets, Volume without news is manipulation. A manipulator can spend less than $8000 a day for one week and trigger a volume alert, drawing in traders who think 80 million shares a day is "huge volume" even though it's only $8000 traded.
That manipulator made a decent profit when the SRL news came out. That manipulator knows how to play the pinksheets.
Gartner missed his August 1st rollout because of a patent problem?
I disagree. I think he has no funding, which means he has no license agreement with Radient.
Why, specifically, does Gartner need the patent approved before he can roll out his LC test?
TIA for answering that question.
you mean the volume of under 80 million a day in late January, starting around the 24th?
80 million shares at .0001 is only $8000 per day. That is your evidence of a takeover? Looks to me like a bunch of pinksheet traders who knew the SRL hype was coming out, so they were setting up for the ensuing manipulation.
The SRL hype news piece came out Feb 1st and that's the day RXPC had 389 million shares traded.
Also I did not hear Gartner say loud and clear that he is waiting for the patent. I heard him say loud and clear that he planned to start selling the test on August 1st.
That new onko-sure patent was rejected twice by the same Patent Examiner over a period of two years, and it's under review now by that same Patent Examiner. It could take another year to get a decision, and there is no guarantee that the decision will be positive. Small-Howard submitted the application on the last possible day -- not a sign of confidence IMO.
AMDL/Radient has had the patents for DR-70/onkosure since the mid 90's.
Another patent on this failed device test is not news. It's not going to cause a PPS spike.
The volume in February was from the SRL "news."
I use quotation marks because the "news" was marketing hype from SRL to sell their DrR-70 tests at half price ($44). That "news story" did not contain any support, recommendation, or confirmation from Indian doctors or the Indian government.
Wolfman claims to own a billion shares. That leaves 3.5 billion shares unaccounted for. $350,000 worth of stock is a small amount on wall street. I fail to see how that constitutes accumulation. That could easily be traders jockeying for what they hope is the next "news."
But please clarify: The creeping takeover has supposedly been happening since February 2011. You are implying the takeover didn't start until February 2013?
The takeover group already took over, says Wolfman.
Wolfman, for those who do not know, is the person responsible for creating the Takeover rumor in 2011. As the situation has degraded, the rumor has gone through many revisions and adjustments. I believe the current version of the takeover rumor goes like this - and if you' taking a drink of something as you're reading is, better put it down, or it will end up on your shirt.
There a multiple takeover groups taking over Radient. Wolfman claims to be controlling one group, with a billion shares. . how these groups will collaborate after they take over is a little fuzzy.
And it has already occurred. The reason there was no 8-K? Because "they don't have to since it's a pink sheet company."
It's not a takeover so much as a back door merger. The fact that it's taken over 2 years makes it a "creeping back door merger." Apparently, Provista wants to be listed on the pink sheets. The Radient lenders have traded all their Radient debt for Provista shares, so the debt is gone says Wolfman. Then Fortis, who owns SRL in India, is buying Provista from the lenders, and buying all the Radient shares from Wolfman and the other groups, which apparently includes William Gartner, who sold a house and used the money to buy Radient shares.
When the dust settles, Provista will have radient's prestigious pink sheet listing, William Gartner will be the new CEO of something, and Wolfman will be rich.
Did I forget to mention - the UNI deal is fake, a diversion. Never happened. And the Fundable contest? Just a publicity stunt, Gartner doesn't need money, he's already CEO of this multi-million-dollar new Provista/Fortis thing.
I'm sure I got something wrong in my summary but that is the gist of it. I invite the proponents of the takeover story to correct me where I am wrong.
the Fundable contest is 30 days.
The GCDx Fundable project is 60 days, with 57 days left.
GCDx obviously didn't just enter a contest for exposure. They are trying to raise $10,000.
The irony here is wonderful.
This Fundable project proves that GCDx is not part of any kind of Radient merger/takeover, but the "longs" are offering it as proof of such a takeover.
More irony: on the Fundable site, GCDx implores us to "Save our Veterans" but shows a picture of a US Flag on the ground -- a picture guaranteed to offend veterans.
No, the Fundable site says 3 months.
Specifically, it says " GCDx will have a GMP licensed manufacturing facility to make their own test reagents and will offer the new Lung Cancer Test in Month 3 following funding. "
That is the second sentence.
GCDX was created in 2012. What's the delay?
UNI signed an agreement for exclusive rights in Asia. Why did Gartner let that happen?
Why haven't you pledged $1000 on Fundable yet?
Longs: pledge $1000 to GCDx on Fundable.
You are "long" because you beleive DR-70 is a viable test, correct?
And you believe that GCDx will be successful?
Then there is no reason not to pledge $1000 to GCDx on Fundable immediately. A $1000 pledge gets you lifetime testing.
If you do not pledge $1000, it means you do not really think DR-70 is a valuable test, or you do not think GCDx will be successful.
Your move.
there is no merger or takeover.
So you're saying the patent is not important, then?